QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 druckenmiller-opens-position-in-amazon-closes-microsoft--heres-more-of-duquesnes-biggest-q3-moves

Stanley Druckenmiller's Duquesne Family Office Q3 13F reinforces the firm's reputation for agile and opportunity-driven...

 stephens--co-maintains-overweight-on-natera-raises-price-target-to-235

Stephens & Co. analyst Mason Carrico maintains Natera (NASDAQ:NTRA) with a Overweight and raises the price target from $...

 piper-sandler-maintains-overweight-on-natera-raises-price-target-to-230

Piper Sandler analyst David Westenberg maintains Natera (NASDAQ:NTRA) with a Overweight and raises the price target from $22...

 morgan-stanley-maintains-overweight-on-natera-raises-price-target-to-220

Morgan Stanley analyst Tejas Savant maintains Natera (NASDAQ:NTRA) with a Overweight and raises the price target from $195 t...

 canaccord-genuity-maintains-buy-on-natera-raises-price-target-to-250

Canaccord Genuity analyst Kyle Mikson maintains Natera (NASDAQ:NTRA) with a Buy and raises the price target from $200 to $250.

 jp-morgan-maintains-overweight-on-natera-raises-price-target-to-240

JP Morgan analyst Casey Woodring maintains Natera (NASDAQ:NTRA) with a Overweight and raises the price target from $210 to $...

 wells-fargo-maintains-equal-weight-on-natera-raises-price-target-to-190

Wells Fargo analyst Brandon Couillard maintains Natera (NASDAQ:NTRA) with a Equal-Weight and raises the price target from $1...

 barclays-maintains-overweight-on-natera-raises-price-target-to-230

Barclays analyst Luke Sergott maintains Natera (NASDAQ:NTRA) with a Overweight and raises the price target from $210 to $230.

 evercore-isi-group-maintains-outperform-on-natera-raises-price-target-to-250

Evercore ISI Group analyst Daniel Markowitz maintains Natera (NASDAQ:NTRA) with a Outperform and raises the price target fro...

 btig-maintains-buy-on-natera-raises-price-target-to-230

BTIG analyst Mark Massaro maintains Natera (NASDAQ:NTRA) with a Buy and raises the price target from $210 to $230.

 natera-raises-fy2025-sales-guidance-from-2020b-2100b-to-2180b-2260b-vs-2091b-est

Natera (NASDAQ:NTRA) raises FY2025 sales outlook from $2.020 billion-$2.100 billion to $2.180 billion-$2.260 billion vs $2.091 ...

 natera-q3-eps-064-misses-040-estimate-sales-592183m-beat-512753m-estimate

Natera (NASDAQ:NTRA) reported quarterly losses of $(0.64) per share which missed the analyst consensus estimate of $(0.40) by 6...

 natera-to-expand-fetal-focus-test-to-cover-20-genes-marking-advancement-in-single-gene-noninvasive-prenatal-testing-new-expanded-panel-to-launch-in-q4-2025

Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA (cfDNA) and precision medicine, today announced it will expand its...

 btig-maintains-buy-on-natera-raises-price-target-to-210

BTIG analyst Mark Massaro maintains Natera (NASDAQ:NTRA) with a Buy and raises the price target from $200 to $210.

 nateras-signatera-demonstrates-predictive-power-in-imvigor011-guiding-tecentriq-use-for-improved-bladder-cancer-outcomes

Data to be featured in Presidential Symposium at ESMOSignatera™ changes the paradigm by expanding the adjuvant decision window,...

 canaccord-genuity-maintains-buy-on-natera-maintains-200-price-target

Canaccord Genuity analyst Kyle Mikson maintains Natera (NASDAQ:NTRA) with a Buy and maintains $200 price target.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION